Patent application number | Description | Published |
20090178160 | Modulation of Triterpenoid Content in Plants - Compositions and methods for producing triterpenoid compounds, e.g., squalene, are disclosed. | 07-09-2009 |
20090241223 | MODULATING PLANT SUGAR LEVELS - This document provides methods and materials related to plants having modulated (e.g., increased) levels of sugars (e.g., glucose, fructose, and/or sucrose). For example, this document provides plants having increased sugar levels as well as methods and materials for making plants and plant products having increased sugar levels. | 09-24-2009 |
20090304901 | MODULATING PLANT PROTEIN LEVELS - Methods and materials for modulating, e.g., increasing or decreasing, protein levels in plants are disclosed. For example, nucleic acids encoding protein-modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also disclosed are plants having increased protein levels and plant products produced from plants having increased protein levels. | 12-10-2009 |
20090324797 | MODULATING PLANT OIL LEVELS - Methods and materials for modulating (e.g., increasing or decreasing) oil levels in plants are disclosed. For example, nucleic acids encoding oil-modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also disclosed are plants having increased oil levels and plant products produced from plants having increased oil levels. | 12-31-2009 |
20090328256 | Sugar Accumulation - Methods and materials for modulating lysine, glucose, fructose, galactose and leucine content in plants are disclosed. | 12-31-2009 |
20110113508 | MODULATING PLANT CAROTENOID LEVELS - Methods and materials for modulating (e.g., increasing or decreasing) carotenoid levels in plants are disclosed. For example, nucleic acids encoding carotenoid-modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also disclosed are plants having increased carotenoid levels and plant products produced from plants having increased carotenoid levels. | 05-12-2011 |
20120331583 | MODULATING PLANT OIL LEVELS - Methods and materials for modulating (e.g., increasing or decreasing) oil levels in plants are disclosed. For example, nucleic acids encoding oil-modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also disclosed are plants having increased oil levels and plant products produced from plants having increased oil levels. | 12-27-2012 |
20130031675 | MODULATING PLANT CARBON LEVELS - Methods and materials for modulating (e.g., increasing or decreasing) carbon levels in plants are disclosed. For example, nucleic acids encoding carbon-modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also disclosed are plants having increased carbon levels. | 01-31-2013 |
20130212735 | MODULATING THE LEVEL OF COMPONENTS WITHIN PLANTS - Materials and Methods for identifying lignin regulatory region-regulatory protein associations are disclosed. Materials and methods for modulating lignin accumulation are also disclosed. In addition, methods and materials for modulating (e.g., increasing or decreasing) the level of a component (e.g., protein, oil, lignin, carbon, a carotenoid, or a triterpenoid) in plants are disclosed. | 08-15-2013 |
Patent application number | Description | Published |
20090118257 | 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES - Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, and stroke (MELAS), Kearns-Sayre Syndrome (KSS), are disclosed, as well as compounds useful in the methods of the invention, such as 4-(p-quinolyl)-2-hydroxybutanamide derivatives. Methods and compounds useful in treating other disorders such as amyotrophic lateral sclerosis (ALS), Huntington's disease, Parkinson's disease, and pervasive developmental disorders such as autism are also disclosed. Energy biomarkers useful in assessing the metabolic state of a subject and the efficacy of treatment are also disclosed. Methods of modulating, normalizing, or enhancing energy biomarkers, as well as compounds useful for such methods, are also disclosed. | 05-07-2009 |
20100035841 | INHIBITORS OF TYROSINE KINASES AND USES THEREOF - Disclosed herein are compounds that inhibit the activity of particular tyrosine kinases. Methods for the preparation of such compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the compounds disclosed, alone or in combination with other therapeutic agents, for the treatment of tyrosine kinase-mediated diseases or conditions or tyrosine kinase-dependent diseases or conditions are provided. | 02-11-2010 |
20100105930 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES - The invention discloses novel processes for production, enrichment and/or isolation of alpha-tocotrienol from source material comprising at least one non-alpha-tocotrienol, such as natural extracts comprising mixed tocotrienols. | 04-29-2010 |
20110124679 | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES - Methods of treating or suppressing oxidative stress diseases including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-substituted-p-quinone derivatives as disclosed herein. | 05-26-2011 |
20110218208 | 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES - Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-heterocyclylaminoalkyl-(p-quinone) derivatives. | 09-08-2011 |
20120083470 | INHIBITORS OF TYROSINE KINASES AND USES THEREOF - Disclosed herein are compounds that inhibit the activity of particular tyrosine kinases. Methods for the preparation of such compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the compounds disclosed, alone or in combination with other therapeutic agents, for the treatment of tyrosine kinase-mediated diseases or conditions or tyrosine kinase-dependent diseases or conditions are provided. | 04-05-2012 |
20120101065 | INHIBITORS OF TYROSINE KINASES AND USES THEREOF - Disclosed herein are compounds that inhibit the activity of particular tyrosine kinases. Methods for the preparation of such compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the compounds disclosed, alone or in combination with other therapeutic agents, for the treatment of tyrosine kinase-mediated diseases or conditions or tyrosine kinase-dependent diseases or conditions are provided. | 04-26-2012 |
20120108547 | INHIBITORS OF TYROSINE KINASES AND USES THEREOF - Disclosed herein are compounds that inhibit the activity of particular tyrosine kinases. Methods for the preparation of such compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the compounds disclosed, alone or in combination with other therapeutic agents, for the treatment of tyrosine kinase-mediated diseases or conditions or tyrosine kinase-dependent diseases or conditions are provided. | 05-03-2012 |
20120122934 | 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES - Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, and stroke (MELAS), Kearns-Sayre Syndrome (KSS), are disclosed, as well as compounds useful in the methods of the invention, such as 4-(p-quinolyl)-2-hydroxybutanamide derivatives. Methods and compounds useful in treating other disorders such as amyotrophic lateral sclerosis (ALS), Huntington's disease, Parkinson's disease, and pervasive developmental disorders such as autism are also disclosed. Energy biomarkers useful in assessing the metabolic state of a subject and the efficacy of treatment are also disclosed. Methods of modulating, normalizing, or enhancing energy biomarkers, as well as compounds useful for such methods, are also disclosed. | 05-17-2012 |
20120130093 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES - The invention discloses novel processes for production, enrichment and/or isolation of alpha-tocotrienol from source material comprising at least one non-alpha-tocotrienol, such as natural extracts comprising mixed tocotrienols. | 05-24-2012 |
20130289034 | 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES - Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, and stroke (MELAS), Kearns-Sayre Syndrome (KSS), are disclosed, as well as compounds useful in the methods of the invention, such as 4-(p-quinolyl)-2-hydroxybutanamide derivatives. Methods and compounds useful in treating other disorders such as amyotrophic lateral sclerosis (ALS), Huntington's disease, Parkinson's disease, and pervasive developmental disorders such as autism are also disclosed. Energy biomarkers useful in assessing the metabolic state of a subject and the efficacy of treatment are also disclosed. Methods of modulating, normalizing, or enhancing energy biomarkers, as well as compounds useful for such methods, are also disclosed. | 10-31-2013 |
20130345312 | TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES - Methods of treating, preventing or suppressing symptoms associated with mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), dominant optic atrophy (DOA); mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), Leigh syndrome or Kearns-Sayre Syndrome (KSS) with compounds of Formula (I) are disclosed. Methods of modulating, normalizing, or enhancing energy biomarkers, as well as compounds useful for such methods are also disclosed. | 12-26-2013 |
20140031432 | TREATMENT OF MITOCHONDRIAL DISEASES WITH VITAMIN K - Methods of treating, preventing or suppressing symptoms associated with mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), dominant optic atrophy (DOA); mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), Leigh syndrome or Kearns-Sayre Syndrome (KSS) with vitamin K are disclosed. | 01-30-2014 |
20140221674 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES - The invention discloses novel processes for production, enrichment and/or isolation of alpha-tocotrienol from source material comprising at least one non-alpha-tocotrienol, such as natural extracts comprising mixed tocotrienols. | 08-07-2014 |
20140323509 | 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES - Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-heterocyclylaminoalkyl-(p-quinone) derivatives. | 10-30-2014 |
20140329860 | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES - Methods of treating or suppressing oxidative stress diseases including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-substituted-p-quinone derivatives as disclosed herein. | 11-06-2014 |
Patent application number | Description | Published |
20120272293 | COLLABORATIVE GATEWAY - A method and a system for monitoring and controlling remote devices are described. The system has a gateway, a web server, and a client device. The gateway is coupled to a security device. The web server has a management application configured to communicate with the gateway. The management application has a service manager module to enable additional services from the gateway and the security device. The client device communicates with the gateway identified by the web server. The gateway aggregates monitoring data from the security device and from other security devices respectively coupled to other gateways correlated with the gateway. The client device receives the aggregated monitoring data, controls the security device coupled to the respective gateway from a web-based user interface at the client device. | 10-25-2012 |
20120310657 | RETURN FRAUD PROTECTION SYSTEM - A method and a system for determining a return fraud at a store are described. The return fraud protection system has a video recording module, a face capture module, a face icon generator module, and an entrance video clip module. The video recording module records a video at an entrance of the store. The face capture module captures a face of a customer entering the store from the video. The face icon generator module generates a face icon comprising the face of the customer. The entrance video clip generator module generates a video clip of the customer entering the store, associates the video clip of the customer with the corresponding face icon, and provides a client device with a list of face icons with corresponding video clips. | 12-06-2012 |
20120310716 | HIGH VALUE DISPLAY CASE SYSTEM - A display case system has a display case, a gateway, and a communication device. The display case houses a product. The gateway is coupled to the display case and communicates with a client device associated with the product in the display case. A communication device is coupled to the gateway and enables a communication session between the communication device and the client device associated with the product. The client device remotely locks and unlocks the display case to allow access to the product based on the communication session. | 12-06-2012 |
20130167190 | MOBILE COMMUNICATION DEVICE SURVEILLANCE SYSTEM - A mobile communication device surveillance system is described. The system includes a gateway, a web server, a wireless mobile communication device, and a client device. The web server introduces the wireless mobile communication device to a gateway. The gateway authenticates the wireless mobile communication device. The gateway receives media data from the wireless mobile communication device and monitoring data from a security device connected to the gateway. The gateway aggregates the media data and the monitoring data, and communicates the aggregated data to the client device authenticated with the gateway. | 06-27-2013 |
20130243269 | DISTRIBUTIVE FACIAL MATCHING AND NOTIFICATION SYSTEM - A method and a system for distributing facial identifiers to gateways are described. The system has one or more gateways and a web server associate with the gateways. Each gateway is coupled to a video capturing device. The web server identifies one or more gateways using a metadata associated with a picture of a face. The web server then distributes the picture of the face and the metadata to the identified gateways. | 09-19-2013 |
20130329047 | ESCORT SECURITY SURVEILLANCE SYSTEM - An escort security surveillance system is described. The system includes a gateway, a web server, a mobile communication device, and a client device of the gateway. The web server introduces the mobile communication device to a corresponding gateway based on a selection of a security monitoring service from the mobile communication device. The mobile communication device has an optical component and a microphone for generating media data. The gateway records a live stream of the media data. The gateway aggregates the media data from the mobile communication device and monitoring data generated by a security device coupled to the gateway. The aggregated data is stored in a storage device and communicated to the client device of the gateway. | 12-12-2013 |
20140254866 | PREDICTIVE ANALYSIS USING VEHICLE LICENSE PLATE RECOGNITION - A method and a system for predictive analysis using vehicle license plate recognition are described. The system has a gateway, a web server, and a client device. The gateway is coupled to security devices. The web server has a management application configured to communicate with the gateway. The client device communicates with the gateway identified by the web server. The gateway monitors data from security devices coupled to the gateway. A predictive behavioral model is generated using historical data from the monitoring data comprising identified characters in license plates of vehicles monitored by the security devices. | 09-11-2014 |
20140254877 | SYSTEM AND METHOD FOR IDENTIFYING A VEHICLE LICENSE PLATE - A method and a system for identifying a license plate of a vehicle are described. The system has a gateway, a web server, and a client device. The gateway is coupled to a security device. The web server has a management application configured to communicate with the gateway. The client device communicates with the gateway identified by the web server. The gateway detects, identifies, and tracks a license plate of a vehicle using a non-infrared camera coupled to the gateway. The gateway generates indicators corresponding to the license plate on a picture generated by the non-infrared camera. | 09-11-2014 |
20140254878 | SYSTEM AND METHOD FOR SCANNING VEHICLE LICENSE PLATES - A method and a system for identifying a license plate of a vehicle are described. The system has a gateway, a web server, and a client device. The gateway is coupled to a security device. The web server has a management application configured to communicate with the gateway. The client device communicates with the gateway identified by the web server. A non-infrared camera connected to the gateway visually scans a location having a plurality of parked vehicles, and identifies characters in the license plates of the plurality of parked vehicles. | 09-11-2014 |
20140259114 | SYSTEM AND METHOD FOR MONITORING A THREAT - A method and a system for monitoring a threat are described. The system has a gateway, a web server, and a client device. The gateway detects, identifies, and tracks a threat at a location associated with the gateway. The gateway is coupled to a security device. The web server has a management application configured to communicate with the gateway. The client device communicates with the gateway identified by the web server. The gateway aggregates monitoring data from the security device and from other security devices respectively coupled to other gateways correlated with the gateway. The client device receives the aggregated monitoring data and controls the security device coupled to the respective gateway from a web-based user interface at the client device. | 09-11-2014 |